- Home
- EU vs RDHL Comparison
EU vs RDHL Comparison
Compare EU & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EU
- RDHL
- Stock Information
- Founded
- EU 2009
- RDHL 2009
- Country
- EU United States
- RDHL Israel
- Employees
- EU N/A
- RDHL N/A
- Industry
- EU Other Metals and Minerals
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- EU Basic Materials
- RDHL Health Care
- Exchange
- EU Nasdaq
- RDHL Nasdaq
- Market Cap
- EU N/A
- RDHL 3.8M
- IPO Year
- EU N/A
- RDHL N/A
- Fundamental
- Price
- EU $1.70
- RDHL $2.00
- Analyst Decision
- EU Strong Buy
- RDHL
- Analyst Count
- EU 2
- RDHL 0
- Target Price
- EU $4.38
- RDHL N/A
- AVG Volume (30 Days)
- EU 1.9M
- RDHL 439.1K
- Earning Date
- EU 05-20-2025
- RDHL 04-10-2025
- Dividend Yield
- EU N/A
- RDHL N/A
- EPS Growth
- EU N/A
- RDHL N/A
- EPS
- EU N/A
- RDHL N/A
- Revenue
- EU $58,334,000.00
- RDHL $8,042,999.00
- Revenue This Year
- EU $27.46
- RDHL $381.91
- Revenue Next Year
- EU $140.12
- RDHL N/A
- P/E Ratio
- EU N/A
- RDHL N/A
- Revenue Growth
- EU 163.38
- RDHL 23.17
- 52 Week Low
- EU $1.01
- RDHL $1.80
- 52 Week High
- EU $4.97
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- EU 59.84
- RDHL 38.79
- Support Level
- EU $1.52
- RDHL $1.85
- Resistance Level
- EU $1.73
- RDHL $2.18
- Average True Range (ATR)
- EU 0.11
- RDHL 0.17
- MACD
- EU 0.04
- RDHL 0.01
- Stochastic Oscillator
- EU 93.33
- RDHL 33.33
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.